Responses
Ovarian cancer
2022-RA-420-ESGO Treatment and outcome of patients with high-grade advanced ovarian cancer (AOC) – real world data of the german quality assurance project (QS Ovar of the AGO Study Group)
Compose a Response to This Article
Other responses
No responses have been published for this article.